Recent
price
P/E
ratio
div
yld
1.88%
ROIC.AI
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity, Data Shows
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity, Data Shows
AstraZeneca COVID therapy succeeds in late-stage study for the vulnerable
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
AstraZeneca selects new heart failure target with BenevolentAI
PRESS DIGEST-British Business - May 14
UK pharma giants pledge £430m investment in France after Macron charm offensive
AstraZeneca, Pfizer to invest combined $900M+ in France for R&D, production
Update: AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Bristol Myers' Opdivo fails in Phase 3 lung cancer study
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
Catalyst's New CEO Has Big Ideas For The Small Biotech
Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Update: AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents
AstraZeneca to withdraw Covid vaccine worldwide, citing a drop in demand
Every household should be forced to have a smart meter, says British Gas boss
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.